Harbor Investment Advisory LLC Purchases 578 Shares of IQVIA Holdings Inc. (NYSE:IQV)
Harbor Investment Advisory LLC Purchases 578 Shares of IQVIA Holdings Inc. (NYSE:IQV)
Harbor Investment Advisory LLC increased its position in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 69.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,406 shares of the medical research company's stock after purchasing an additional 578 shares during the quarter. Harbor Investment Advisory LLC's holdings in IQVIA were worth $305,000 at the end of the most recent quarter.
根据港湾投资咨询公司在最近向美国证券交易委员会(美国证券交易委员会)披露的信息，该公司在第二季度将其在IQVIA Holdings Inc.(纽约证券交易所代码：IQV-GET评级)的持仓增加了69.8%。该公司在本季度额外购买了578股后，持有这家医学研究公司1,406股股票。截至最近一个季度末，Harbor Investment Consulting LLC持有的IQVIA股份价值30.5万美元。
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Riverview Trust Co bought a new position in IQVIA in the first quarter worth $25,000. Dividend Assets Capital LLC bought a new position in IQVIA in the first quarter worth $27,000. Johnson Financial Group Inc. bought a new position in IQVIA in the fourth quarter worth $34,000. Quent Capital LLC lifted its holdings in shares of IQVIA by 271.8% during the first quarter. Quent Capital LLC now owns 145 shares of the medical research company's stock valued at $34,000 after acquiring an additional 106 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of IQVIA by 243.2% during the first quarter. EverSource Wealth Advisors LLC now owns 151 shares of the medical research company's stock valued at $35,000 after acquiring an additional 107 shares during the period. 86.77% of the stock is owned by institutional investors.
其他对冲基金和其他机构投资者最近也买卖了该公司的股票。Riverview Trust Co在第一季度购买了价值25,000美元的IQVIA新头寸。红利资产资本有限责任公司在第一季度购买了价值2.7万美元的IQVIA新头寸。约翰逊金融集团(Johnson Financial Group Inc.)在第四季度购买了价值3.4万美元的IQVIA新头寸。Quent Capital LLC在第一季度增持了271.8%的IQVIA股票。Quent Capital LLC在此期间增持了106股，现在拥有145股这家医疗研究公司的股票，价值3.4万美元。最后，Eversource Wealth Advisors LLC在第一季度增持了243.2%的IQVIA股票。Eversource Wealth Advisors LLC在此期间增持了107股，现在拥有151股这家医疗研究公司的股票，价值3.5万美元。86.77%的股份由机构投资者持有。
Analyst Upgrades and Downgrades
分析师升级和下调评级
A number of research analysts have issued reports on the company. Guggenheim lifted their price objective on IQVIA to $246.00 in a report on Friday, July 22nd. Morgan Stanley lifted their price objective on IQVIA from $255.00 to $260.00 and gave the company an "overweight" rating in a report on Friday, July 22nd. Evercore ISI lifted their price objective on IQVIA from $265.00 to $275.00 in a report on Friday, July 22nd. Credit Suisse Group began coverage on IQVIA in a report on Wednesday, August 24th. They set an "outperform" rating and a $300.00 price objective for the company. Finally, Robert W. Baird raised their target price on IQVIA from $260.00 to $265.00 in a research note on Friday, July 22nd. Two research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $275.00.
一些研究分析师已经发布了关于该公司的报告。古根海姆在7月22日星期五的一份报告中将IQVIA的目标价格上调至246.00美元。摩根士丹利在7月22日周五的一份报告中将IQVIA的目标价从255.00美元上调至260.00美元，并给予该公司“增持”评级。在7月22日星期五的一份报告中，Evercore ISI将IQVIA的目标价从265.00美元上调至275.00美元。瑞士信贷集团在8月24日星期三的一份报告中开始对IQVIA进行报道。他们为该公司设定了“跑赢大盘”的评级和300.00美元的目标股价。最后，罗伯特·W·贝尔德在7月22日星期五的一份研究报告中将IQVIA的目标价从260.00美元上调至265.00美元。两名研究分析师对该股的评级为持有，15名分析师对该公司股票的评级为买入。根据MarketBeat.com的数据，该股目前的平均评级为“中等买入”，共识目标价为275.00美元。
IQVIA Price Performance
IQVIA性价比
IQVIA (NYSE:IQV – Get Rating) last announced its quarterly earnings data on Thursday, July 21st. The medical research company reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $2.21 by $0.04. The firm had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.49 billion. IQVIA had a return on equity of 30.21% and a net margin of 8.21%. The company's revenue was up 3.0% on a year-over-year basis. During the same period last year, the company earned $1.94 earnings per share. Research analysts expect that IQVIA Holdings Inc. will post 9.4 EPS for the current year.
IQVIA(纽约证券交易所代码：IQV-GET Rating)上一次公布季度收益数据是在7月21日星期四。这家医疗研究公司公布本季度每股收益为2.25美元，比分析师普遍预期的2.21美元高出0.04美元。该公司本季度营收为35.4亿美元，而分析师预期为34.9亿美元。IQVIA的股本回报率为30.21%，净利润率为8.21%。该公司的收入同比增长了3.0%。去年同期，该公司每股收益为1.94美元。研究分析师预计，IQVIA Holdings Inc.将公布本年度每股收益9.4%。
About IQVIA
关于IQVIA
(Get Rating)
(获取评级)
IQVIA Holdings Inc provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
IQVIA控股公司为美洲、欧洲、非洲和亚太地区的生命科学行业提供先进的分析、技术解决方案和临床研究服务。它通过三个部门运作：技术和分析解决方案、研发解决方案和合同销售和医疗解决方案。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on IQVIA (IQV)
- MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
- Is the Market Overreacting with Shopify Stock?
- MO Money: Why Altria Group Stock is Rallying
- Fed Raises Rates: 3 Stocks to Watch Newmont Mining, Walmart, AMC
- Three Consumer Stocks That Could Outperform In Q4
- 免费获取StockNews.com关于IQVIA(IQV)的研究报告
- MarketBeat Podcast，3只股票关注纽蒙特矿业、沃尔玛、AMC
- 市场是否对Shopify Stock反应过度？
- Mo Money：奥驰亚集团股价为何上涨
- 美联储加息：3只股票关注纽蒙特矿业、沃尔玛、AMC
- 三只可能在第四季度表现优异的消费类股
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Get Rating).
想看看还有哪些对冲基金持有IQV吗？访问HoldingsChannel.com获取IQVIA Holdings Inc.(纽约证券交易所代码：IQV-GET Rating)的最新13F文件和内幕交易信息。
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.
接受IQVIA日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对IQVIA和相关公司的最新新闻和分析师评级的每日简要摘要。